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Granulosa cell (GC) inhibin A and B production is regulated by FSH and gonadal factors. This gonadotrophin is released as a mixture of
glycoforms, which induce different biological responses in vivo and in vitro. Our aim was to determine the effect of recombinant human
FSH (rhFSH) glycosylation variants on inhibin A and B production by rat GCs. Preparative isoelectro focusing was used to isolate more
acidic/sialylated (pH!4.00) and less acidic/sialylated (pH O5.00) rhFSH charge analogues. Concanavalin A was used to isolate
unbound and firmly bound rhFSH glycoforms on the basis of their oligosaccharide complexity. GCs, obtained from oestrogen-primed
immature rats, were cultured with either native rhFSH or its glycosylation variants. Inhibin A and B were determined using specific
ELISAs. Results were expressed as meanGS.E.M. Under basal conditions, inhibin A was the predominant dimer produced (inhibin A:
673G55; inhibin B: 80G4 pg/ml). More acidic/sialylated charge analogues stimulated inhibin B production when compared to inhibin A
at all doses studied; by contrast, less acidic/sialylated charge analogues stimulated inhibin A production and elicited no effect on
inhibin B. Glycoforms bearing complex oligosaccharides showed a potent stimulatory effect on inhibin B when compared to inhibin A
production (i.e. dose 1 ng/ml: 4.9G0.5 vs 0.9G0.1-fold stimulation, P!0.001). Glycoforms bearing hybrid-type oligosaccharides
favoured inhibin A production (i.e. dose 4 ng/ml 2.9G0.1 vs 1.6G0.1-fold stimulation, P!0.05). These results show that the sialylation
degree as well as the complexity of oligosaccharides present in the rhFSH molecule may be considered additional factors that
differentially regulate dimeric inhibin production by rat GCs.
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Inhibin A and B are the relevant forms of circulating
dimeric inhibins in human and rodents; changes in their
plasma concentration during the menstrual/oestrous
cycle have been described. In women, inhibin B levels
are maximal in the mid-follicular phase and fall before
ovulation, remaining low during the luteal phase,
whereas inhibin A remains low during the early- and
mid-follicular phase and predominates in the luteal
phase of the menstrual cycle (Groome et al. 1994, 1996,
Sehested et al. 2000). In female rats, inhibin B serum
levels peak early in the oestrous cycle, whereas
circulating inhibin A increases gradually until just before
the primary gonadotrophin surge (Woodruff et al. 1996,
Arai et al. 2002). The regulation of dimeric inhibin
production is complex; FSH, growth factors and the
stage of follicle development contribute to the differ-
ential regulation of inhibin A and B. We have previously
shown that rat granulosa cells (GCs) are able to secrete
dimeric inhibins; this production, as well as the ratioq 2013 Society for Reproduction and Fertility
ISSN 1470–1626 (paper) 1741–7899 (online)between inhibin A and B, is regulated by FSH, oestrogen
and growth factors. Inhibin A seems to be more sensitive
to FSH stimulation during the later stages of follicular
growth, whereas inhibin B seems to reflect the action of
the members of the TGF-b superfamily in preantral
follicles (Lanuza et al. 1999).
FSH is secreted in multiple glycosylation variants,
which differ from each other in their sialic acid content
and inner carbohydrate structure (Ulloa-Aguirre et al.
1999). Specific patterns of FSH glycoforms are associ-
ated with the degree of ovarian activity. We have
previously shown that a characteristic feature of serum
FSH in the follicular phase of young women, whose
inhibin B levels are within the normal range, is the
predominance of an acidic mix of FSH glycosylation
variants, bearing highly branched oligosaccharides. By
contrast, during the perimenopause and lactational
amenorrhoea, two conditions characterized by dimin-
ished ovarian activity in the presence of normal
immunoreactive FSH circulating levels, there is aDOI: 10.1530/REP-12-0228
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variants bearing highly branched oligosaccharides and
appear in circulation those bearing incomplete, hybrid
type carbohydrate chains. These changes in the micro-
heterogeneity of circulating FSH were associated with a
significant decrease in inhibin B serum levels (Velasquez
et al. 2006, Loreti et al. 2009).
In rodents, FSH sialylation varies according to the
day and time of the oestrous cycle (Ulloa-Aguirre et al.
1988). Furthermore, it has been shown that the structure
of oligosaccharides present in the FSH molecule induces
a differential response in rat GCs in terms of oestradiol
production (Ulloa-Aguirre et al. 1995). The pattern of
follicular development and oocyte quality in mice are
also strongly influenced by rhFSH sialylation (Nayudu
et al. 2002).
It remains to be established whether the structure of
the oligosaccharides present in the FSH molecule may
affect other aspects of the endocrine activity in GCs. The
aim of this study was to determine the effect of
recombinant human FSH (rhFSH) sialylation and carbo-
hydrate complexity on inhibin A and B GC production.Results
The isolation of rhFSH glycosylation variants according
to their sialylation degree and oligosaccharide complex-
ity was carried out as depicted in Fig. 1.Distribution profile of rhFSH charge analogues
The relative proportion of rhFSH charge analogues
recovered in 0.29 pH units, after preparative isoelectric
focusing (IEF), is shown in Fig. 2A. The gonadotrophin
was detected in 12 fractions of the gradient, within aIEF
rhF
AC
pH<4
BA
pH>5
ConA ConA
ACUB ACWB ACFB BAUB BAWB B
Figure 1 General outline of the analytical procedure followed to isolate and c
preparative isoelectric focusing) and oligosaccharide complexity (ConA, conca
pH!4; BA: less sialylated charge analogues isolated at pHO5. Oligosacchari
shown: UB, unbound, triantennary and bisecting oligosaccharides; WB, weak
bound, high mannose and hybrid-type oligosaccharides. ACUB,WB,FB, unboun
unbound, weakly and firmly bound less sialylated charge analogues. Asn, asp
closed diamond, galactose; closed down triangle, fucose; uparrow, sialic acid
Reproduction (2013) 145 127–135pH range of 3.20–5.90. A predominant proportion
(35.9G4.8%, P!0.001) of rhFSH charge analogues
focused at a 4.40–4.69 pH interval. A lower proportion
of the hormone was isolated either below pH 4.10
(22.8G8.3%) or above pH 5.00 (17.0G1.7%). Inorder to
obtain a more acidic/sialylated charge analogues mix
(rhFSH-AC), fractions from pH 2.56 to 4.00 were
combined and concentrated; fractions at pHO5.00 were
combined to obtain a less acidic/sialylated preparation
(rhFSH-BA). These two rhFSH preparations were selected
to explore the effect of their sialylation degree on inhibin
production, based on the previously observed variations
in the relative proportion of circulating gonadotrophin
isolated at these two pH intervals that were associated
with changes in ovarian activity in normal women
(Velasquez et al. 2006, Loreti et al. 2009).Distribution profile of native rhFSH glycoforms after
concanavalin A chromatography
In order to isolate rhFSH glycosylation variants on the
basis of its carbohydrate complexity, concanavalin A
(ConA) chromatography was used. The three groups
of glycoforms disclosed by lectin were detected in
native rhFSH: unbound glycoforms bearing complex,
triantennary and bisecting oligosaccharides (rhFSH-UB);
weakly bound glycoforms bearing biantennary and
truncated oligosaccharides (rhFSH-WB), and firmly
bound glycoforms bearing high mannose and hybrid-
type oligosaccharides (rhFSH-FB). A clear predominance
of glycoforms bearing high mannose and hybrid-type
oligosaccharides was observed (70.7G4.9% vs 18.3
G4.7% and 12.3G3.5%, rhFSH-FB vs rhFSH-WB and
rhFSH-UB respectively, P!0.001) (Fig. 2B). To confirm
this finding, rhFSH-FB glycoforms were re-analysed in aSH
UB WB FB
ConA
-Asn- -Asn- -Asn- -Asn- -Asn- -Asn-
AFB
± ± ± ± ±
haracterize rhFSH glycosylation variants according to their charge (IEF,
navalin A chromatography). AC: more acidic charge analogues isolated at
de structures of rhFSH glycoforms isolated after ConA chromatography are
ly bound, biantennary and truncated oligosaccharides; and FB, firmly
d, weakly and firmly bound more acidic charge analogues; BAUB,WB,FB,
aragine; closed square, N-acetylglucosamine; closed circle, mannose;
;G with or without sialic acid.
www.reproduction-online.org
UB WB FB
0
25
50
75
100B
***
rhFSH:
%
 To
ta
l r
ec
ov
e
re
d 
FS
H
WB FB
0
20
40
60
80
100
%
 To
ta
l r
e
co
ve
re
d
FS
H
< 
3.2
0
3.2
0–
3.4
9
3.5
0–
3.7
9
3.8
0–
4.0
9
4.1
0–
4.3
9
4.4
0–
4.6
9
4.7
0–
4.9
9
5.0
0–
5.2
9
5.3
0–
5.5
9
5.6
0–
5.8
9
>5
.90
0
10
20
30
40
50A
***
pH range
%
 To
ta
l r
ec
ov
e
re
d 
FS
H
Figure 2 Distribution profile of rhFSH charge analogues after IEF,
isolated within pH intervals of 0.29 units in a pH 3–10 gradient (A).
Distribution profile of rhFSH glycosylation variants isolated by
concanavalin A chromatography (B): unbound (rhFSH-UB: triantennary
and bisecting oligosaccharides); weakly bound (rhFSH-WB: biantenn-
ary and truncated oligosaccharides) and firmly bound (rhFSH-FB: high
mannose and hybrid-type oligosaccharides). Inset: Re-chromatography
of rhFSH-FB fraction. Results are expressed as meanGS.E.M. percentage
of total recovered rhFSH of triplicate incubations of three independent
experiments. ***P!0.001, proportion of rhFSH isolated at a pH
interval of 4.40–4.69 vs those isolated at pH intervals above and below
these values (A). ***P!0.001, rhFSH-FB proportion vs rhFSH-UB and
rhFSH-WB proportions (B).
FSH glycoforms and dimeric inhibin production 129new ConA column; 90% of the hormone was again
firmly bound to the lectin.
To explore the effect of rhFSH carbohydrate complex-
ity on inhibin production by GCs, glycoforms bearing
complex oligosaccharides and those bearing high
mannose and hybrid-type oligosaccharides, with marked
differences in the complexity of their oligosaccharides,
were selected. In previous studies, we found that it was
the relative proportion of these two types of glycosyla-
tion variants that were more affected by changes in
ovarian cyclicity and ageing in normal women. FSH
glycoforms, bearing triantennary and bisecting oligo-
saccharides, circulate in the follicular phase of the
normal menstrual cycle, when a fully functional gonad is
present; however, they are absent in postmenopausalwww.reproduction-online.orgwomen (Creus et al. 1996, Velasquez et al. 2006).
During the perimenopause, there is a relative decrease
in circulating FSH glycoforms bearing triantennary and
bisecting oligosaccharides, concomitantly with the
appearance of a small proportion of glycosylation
variants bearing high mannose and hybrid-type oligo-
saccharides (Loreti et al. 2009).Distribution profile of more and less sialylated rhFSH
after ConA chromatography
The more acidic/sialylated and the less sialylated rhFSH
charge analogues (rhFSH-AC and rhFSH-BA) were
concentrated and individually applied to ConA columns
in order to characterize the glycosylation variants on
the basis of their oligosaccharide complexity (Fig. 3A
and B). A clear predominance of rhFSH glycoforms
bearing complex oligosaccharides was observed when
the more acidic/sialylated rhFSH charge analogue
preparation was analysed (rhFSH-ACUB: 39.5G5.5%
and rhFSH-ACWB: 45.5G7.5% of total recovered
rhFSH); a lower proportion of glycoforms bearing high
mannose and hybrid-type oligosaccharides was found
(rhFSH-ACFB15.0G2.0, P!0.01).
rhFSH glycoforms bearing high mannose and
hybrid-type oligosaccharides (rhFSH-BAFB) were the
more abundant glycosylation variants found in the
less acidic preparation (83.8G7.7% vs 13.0G6.1%
and 3.3G1.8%, rhFSH-BAFB vs rhFSH-BAWB and
rhFSH-BAUB respectively, P!0.001).Effect of native rhFSH on inhibin A and B production
Rat GCs, cultured under basal conditions, predomi-
nantly produced inhibin A (inhibin A, 673G55; inhibin
B, 80G4 pg/ml); the INHA/INHB ratio was 8.4G0.3.
To assess the effect of rhFSH on the production of
both inhibins, GCs were cultured with increasing doses
of gonadotrophin (0.5–16 ng/ml). As shown in Table 1,
rhFSH favoured inhibin A production; the lowest dose
used (0.5 ng/ml) was able to significantly stimulate the
production of this dimer (P!0.01 when compared to
basal). The lowest dose of rhFSH that was effective to
induce an increase in inhibin B secretion was 4 ng/ml
(P!0.05 when compared to basal).Effect of rhFSH sialylation on inhibin A and B
production
When rat GCs were stimulated with more and less
acidic/sialylated rhFSH charge analogues, there was a
differential effect on inhibin production depending on
the charge analogues mix to which the cells were
exposed (Fig. 4). More acidic/sialylated charge ana-
logues isolated at pH below 4 (rhFSH-AC) stimulated
inhibin B production (3.6- to 13.7-fold over basal,Reproduction (2013) 145 127–135
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Figure 3 Distribution profile of rhFSH charge analogues after
concanavalin A chromatography. rhFSH-AC: more acidic charge
analogues isolated at pH!4 (A); rhFSH-BA: less sialylated charge
analogues isolated at pHO5 (B). rhFSH-ACUB, unbound, triantennary
and bisecting oligosaccharides; rhFSH-ACWB, weakly bound, bian-
tennary and truncated oligosaccharides and rhFSH-ACFB, firmly bound,
high mannose and hybrid-type oligosaccharides. Results are expressed
as meanGS.E.M. percentage of total recovered rhFSH of triplicate
incubations of three independent experiments. *P!0.05; ***P!0.001,
FB proportion vs UB and WB proportions.
130 N Loreti and othersP!0.01) over a dose range of 1–16 ng/ml. Only minor
changes were observed in inhibin A production, even at
the highest doses (8 and 16 ng/ml) used in the culture:
1.3- and 2.9-fold stimulation over basal respectively.
By contrast, the cells exposed at the less acidic/sialylated
counterparts isolated at pH above 5 (rhFSH-BA)
responded with a marked increment of inhibin A
secretion (from 4.9- to 7.6-fold stimulation over basal)
at a dose range of 2–16 ng/ml; no effect was observed
on inhibin B production at any of the doses studied.Table 1 Effect of native rhFSH on inhibin A and B production by rat granul
rhFSH (ng/ml) 0 0.5 1
INHA (pg/ml) 673G55 1117G86† 1142G54†
INHB (pg/ml) 80G4 82G7 100G13
Rat granulosa cells were cultured for 72 h with or without increasing concen
hFSH-2 standard, NIDDKNHPP). Inhibins A (INHA) and B (INHB) were dete
of triplicate incubations of three independent experiments. *P!0.05; †P!
Reproduction (2013) 145 127–135Effect of rhFSH glycan branching
The complexity of rhFSH oligosaccharides also affected
dimeric inhibin production (Fig. 5). Both rhFSH glycosy-
lation variants, rhFSH-UB and rhFSH-FB, stimulated the
production of inhibin A and B; however, those bearing
triantennary and bisecting oligosaccharides (rhFSH-UB)
clearly favoured inhibin B production. A significant
increment was observed at a low dose, 1 ng/ml: 4.9G
0.5-fold stimulation over basal (P!0.05); maximal
stimulation was reached at the dose of 2 ng/ml (6.9G
0.4-fold stimulation over basal). Under these experi-
mental conditions, inhibin A was not affected. Higher
doses of rhFSH-UB glycoforms were needed to signi-
ficantly increase inhibin A production: 4–16 ng/ml (1.9-
to 7.5-fold stimulation over basal, P!0.01) (Fig. 5A).
rhFSH glycoforms bearing high mannose and hybrid-
type oligosaccharides (rhFSH-FB fraction) stimulated
inhibin A production over a range of doses between 4
and 16 ng/ml (2.9- to 9.0-fold stimulation over basal,
P!0.001). Minor changes were observed in inhibin B
production at the highest doses used in the culture (Fig. 5B).Discussion
The differential actions of FSH glycosylation variants
on GC function and follicular development have
been previously reported (Ulloa-Aguirre et al. 1995,
Vitt et al. 1998). The results obtained in this study show,
for the first time, that this differential action of FSH
glycosylation on GCs also affects inhibin production.
rhFSH was used to isolate glycosylation variants,
based on their carbohydrate sialylation and complexity,
considering that this preparation is extremely pure and
has no LH contamination (Loumaye et al. 1995). The
results obtained herein confirmed previous reports
describing the isolation of rhFSH charge analogues
within a pH range similar to that found in this study;
the predominant proportion of the gonadotrophin was
also isolated at a similar pH interval (Horsman et al.
2000). Nevertheless, the proportion of more acidic/
sialylated charge analogues (isolated below pH 4.4) was
clearly lower in the rhFSH preparation when compared
with that physiologically secreted during the follicular
phase of the normal menstrual cycle (Zambrano et al.
1995, Velasquez et al. 2006, Loreti et al. 2009).
When the carbohydrate complexity of glycosylation
variants was analysed, a clear predominance of glyco-
forms bearing incomplete carbohydrates was found inosa cells.
2 4 8 16
1397G151‡ 1854G185‡ 2368G200‡ 4159G69‡
123G15 129G5* 174G17‡ 338G27‡
trations of native recombinant human FSH (rhFSH; expressed in terms of
rmined in the conditioned media. Results are expressed as meanGS.E.M.
0.01; ‡P!0.001 compared with respective control.
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Figure 5 Effect of rhFSH glycan branching on inhibin A (INHA) and
inhibin B (INHB) production by rat granulosa cells (GCs). GCs were
cultured with or without increasing concentrations of rhFSH glyco-
forms bearing triantennary and bisecting oligosaccharides (rhFSH-UB;
A) and glycoforms bearing high mannose and hybrid-type oligo-
saccharides (rhFSH-FB; B). The rhFSH dose is expressed in terms of
hFSH-2 standard (NIDDKNHPP). Inhibin A and B were determined in
the conditioned media after 72 h of culture. Results are presented as
fold stimulation over respective basal production. Values are meanG
S.E.M. of triplicate incubations of three independent experiments.
*P!0.05; **P!0.01; ***P!0.001 compared with respective control.
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Figure 4 Effect of sialylation degree of rhFSH on inhibin A (INHA) and
inhibin B (INHB) production by rat granulosa cells (GCs). GCs were
cultured with or without increasing concentrations of more acidic
charge analogues isolated at pH!4, rhFSH-AC (A), and less acidic
charge analogues isolated at pHO5, rhFSH-BA (B). The rhFSH dose is
expressed in terms of hFSH-2 standard (NIDDKNHPP). Inhibin A and B
were determined in the conditioned media after 72 h of culture. Results
are presented as fold stimulation over respective basal production.
Values are meanGS.E.M. of triplicate incubations of three independent
experiments. *P!0.05; **P!0.01; ***P!0.001 compared with
respective control.
FSH glycoforms and dimeric inhibin production 131this preparation. These results were not unexpected
considering the source of production of this hormone,
the CHO cells. This non-human cell line does not
express b-galactoside a2,6-sialyltransferase and
N-acetylglucosaminyltransferase III. Therefore, only
a2,3-linked sialic acid residues are added to rhFSH
carbohydrate chains and there is no possibility to add
bisecting GlcNAc residues to generate oligosaccharide
complex structures (Ha˚rd et al. 1990, Xu et al. 2011).
Interestingly, the physiologically produced FSH in the
human pituitary contains not only a2,3-linked but also
a2,6-linked sialic acid residues (Green & Baenziger
1988), and glycoforms bearing complex oligosacchar-
ides are predominant in human pituitary extracts (Creus
et al. 2001). It is worth noting that the differences in the
characteristic of the carbohydrates present in the FSH
molecule, currently used to stimulate follicularwww.reproduction-online.orgdevelopment and ovulation, may have a relevant impact
on GC endocrine function.
It has been demonstrated that differences in FSH
sialylation affect GC as well as follicular functions. In
particular, a differential regulation induced by pituitary
FSH charge analogues on inhibin a-subunit expression
has been reported using a similar experimental model
(Timossi et al. 2000). Our results showed that the
sialylation degree of rhFSH is involved in the differential
secretion of a specific inhibin dimer. It was clear that
more sialylated rhFSH favoured inhibin B production; the
less sialylated counterparts were not able to stimulate
inhibin B but exerted a marked stimulatory effect on
inhibin A. This particular effect exerted by the rhFSH
degree of sialylation on the GC may contribute to the
characteristic pattern of dimeric inhibin secretion profileReproduction (2013) 145 127–135
132 N Loreti and othersobserved across the menstrual cycle. FSH sialic acid
content varies across the menstrual cycle (Padmanabhan
et al. 1988, Zambrano et al. 1995); concomitantly with
the presence of more acidic FSH, raising serum inhibin B
concentrations are observed in the early follicular phase
of the menstrual cycle, whereas the less acidic counter-
parts found in the late follicular phase are associated
with the appearance of inhibin A in circulation.
In a previous study, we showed that not only the
degree of sialylation but also the complexity of the FSH
carbohydrate influences the biological response in the
Sertoli cell in terms of oestradiol production (Creus et al.
2001). Dimeric production in GCs was also affected by
the oligosaccharide structure of rhFSH; however, it is
worth noting that the differential effect induced by
oligosaccharide complexity was not identical to that
exerted by the degree of hormone sialylation. rhFSH
glycosylation variants bearing complex oligosaccharides
(rhFSH-UB) were able to stimulate inhibin A and B.
Nevertheless, GCs showed a high sensitivity to respond
to these glycosylation variants producing, predomi-
nantly, inhibin B. The differential effect of oligosac-
charide complexity on inhibin production disappeared
when cells were exposed to high doses of the hormone.
The analysis of the oligosaccharide complexity in
the more and less sialylated rhFSH charge analogues
revealed the predominance of oligosaccharides that
have completed the addition of all sugar residues
in the rhFSH-AC preparation and the presence of a
very high proportion of incomplete, high mannose/
hybrid-type oligosaccharides in the rhFSH-BA preparation.
Recent studies have shown that pituitary hFSH
consists of two classes of molecules: those that possess
a non-glycosylated b-subunit and those that possess
di-glycosylated b-subunits (Walton et al. 2001, Bousfield
et al. 2007). These differences impact on the b-subunit
and FSH molecular weight. It cannot be ruled out that
in our preparations, particularly in rhFSH-BA and
rhFSH-FB, non-glycosylated b-subunits may be present.
However, the differential effects exerted by rhFSH
glycosylation variants on inhibin production by GCs
cannot account for variations in the gonadotrophin mass
added to the cultures. The amount of native rhFSH as
well as its glycosylation variants was evaluated by RIA
using a polyclonal antibody that is unable to differentiate
the rhFSH glycosylation variants according to their
molecular weight. All the glycosylation variants isolated
from rhFSH showed the same affinity for the antibody
when referred to an identical standard: LER 907. This
standard was previously used to evaluate immunological
FSH activity when the in vitro biopotency of different
hFSH preparations was assessed (Zambrano et al. 1996,
Yding Andersen et al. 1999).
Based on all these findings, it can be concluded that
GCs need the stimulus of an FSH molecule bearing
two concomitant characteristics: a heavily sialylated
carbohydrate chain and a complex carbohydrate chainReproduction (2013) 145 127–135in order to produce inhibin B. On the other hand, inhibin
A production may not require such a strict molecular
feature; it may be stimulated by an FSH molecule
bearing different degrees of oligosaccharide complexity,
but the presence of an abundant sialic acid content in
the oligosaccharide moiety of the gonadotrophin might
hinder the production of this dimer.
Further studies will be needed to elucidate the
molecular mechanism induced by FSH glycosylation
variants to exert this differential regulation on GC inhibin
production. Unlike the a- and bA subunits, transcription
of the bB-subunit is not regulated by cAMP-responsive
elements (Dykema & Mayo 1994) and the canonical
Gs/cAMP/PKA pathway is not the unique mechanism
leading to FSH biological actions (Gloaguen et al. 2011).
Therefore, it can be speculated that specific signal
transduction pathways could be activated by FSH
glycoforms in order to induce not only the expression
of inhibin/activin subunits but also other genes involved
in the regulation of important regulatory mechanisms
of GC function.Materials and Methods
Reagents
rhFSH was purchased from the National Hormone and Peptide
Program of the National Institute of Diabetes, Digestive and
Kidney Diseases (NIDDK)-NIH (Torrance, CA, USA). Diethyl-
stilbestrol (DES) was purchased from Sigma–Aldrich, Inc.
DMEM, nutrient Mixture F-12 (Ham), fungizone (250 mg/ml)
and gentamicina (10 mg/ml), was obtained from Invitrogen.
All other chemicals were of reagent grade from standard
commercial sources.Rat GC isolation and culture
Ovaries were obtained from 21- to 23-day-old immature
female Sprague–Dawley rats, injected s.c. with 1 mg DES daily
for 3 days. Animals were killed by cervical dislocation, and all
experimental procedures were performed in compliance with
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals and approved by the local Institutional
Ethic Committee (IBYME-CONICET). GCs were isolated by
follicular puncture, as described previously (Bley et al. 1992).
Cells were seeded onto plastic 96-well plates (Nunc, Roskilde,
Denmark). Initial plating density was 2!105 viable cells/cm2
and cells were maintained at 37 8C with 5% CO2. After 2 h,
medium was changed to remove non-attached cells and
replaced with fresh DMEM:F12 (1:1, vol/vol)–bicarbonate
(2.2 g/l) supplemented with fungizone, gentamicin, in the
absence or presence of native rhFSH and its glycosylation
variants (0.5–16 ng/ml) for 72 h.Isolation of rhFSH glycosylation variants
Glycosylation variants were isolated according to either their
charge or their oligosaccharide complexity. Two native rhFSHwww.reproduction-online.org
FSH glycoforms and dimeric inhibin production 133ampoules (40 mg LER-907) were applied for each procedure;
three independent and consecutive analyses were carried out.
The content of each ampoule was dissolved in double-distilled
and deionized water (Barnstead NANOPure II, Thermo
Scientific, Baltimore, MD, USA) and applied into a preparative
IEF cell or into a ConA column.Preparative IEF
Preparative IEF was used to isolate rhFSH charge analogues
according to their sialylation degree using a Rotofor system
(Rotofor Preparative Cell, Bio-Rad Laboratories, Inc.) as
described previously (Bedecarra´s et al. 1998, Loreti et al.
2009). Focusing was carried out at 12 W constant power
(Power Pac 3000 Bio-Rad Laboratories, Inc.) for 4 h, maintain-
ing the chamber refrigerated (Refrigerated Circulator, Forma
Scientific, Inc., Marietta, OH, USA). Twenty fractions (2.5 ml
each) were harvested and their pH was determined. Each
individual fraction was exhaustively dialysed against 1 mol/l
NaCl to completely eliminate ampholytes and detergent
and I-FSH content was determined by double-antibody RIA.
The range of recovered FSH was 70–85%. Fractions from
pH 2.56 to 4.00 (rhFSH-AC) and at pH O5.00 (rhFSH-BA)
were combined and concentrated using Centriprep-10 mem-
brane (cut-off 10 000; Amicon, Beverly, MA, USA) and stored
atK20 8C.ConA chromatography
ConA chromatography was used to isolate three groups of
rhFSH glycosylation variants according to the complexity
of their oligosaccharides. The isolation of these three groups
of glycoforms was based on the different affinities that the
carbohydrate structures have for this particular lectin.
Galactosyl residues present in glycoproteins bearing complex
type or highly branched oligosaccharides do not interact with
the lectin, unbound fraction: UB (Goldstein et al. 1965). On the
contrary, carbohydrate chains containing two interacting
a-mannopyranosyl residue, frequently present in high mannose
and hybrid-type oligosaccharides, are strongly retained in the
column, firmly bound fraction: FB (Ogata et al. 1975). The
presence of N-acetylglucosamine residues, frequently present
in glycoproteins bearing biantennary and truncated carbo-
hydrate chains, considerably weakens binding to the lectin,
weakly bound fraction: WB (Goldstein et al. 1965). The
technique described by Narasimhan et al. (1979), modified by
Cheng et al. (1984) and Creus et al. (1996), was employed.
Briefly, equilibrium buffer (50 mm Tris–HCl; pH 7.4, 0.5 M
NaCl, 1 mM MgCl2, 1 mM CaCl2, and 1 mM MnCl2) was used
to elute unbound rhFSH glycoforms (rhFSH-UB); equilibrium
buffer containing 10 mM methyl-a-D-glucopyranoside (gluco-
side) was used to elute the weakly bound rhFSH glycoforms
(rhFSH-WB) and equilibrium buffer containing 0.1 M methyl-a-
D-mannopyranoside (mannoside) was used to elute the firmly
bound rhFSH glycoforms (rhFSH-FB).
Eluates containing rhFSH-UB, -WB and -FB glycoforms were
dialysed against 0.01 mol/l NaCl and concentrated (Centriprep
membranes, Amicon). The procedure was carried out at 4 8C.
The range of recovered rhFSH was 75–90%. The distributionwww.reproduction-online.orgprofile of rhFSH glycoforms was obtained by considering each
fraction as a proportion of the total rhFSH recovered after ConA
chromatography.Distribution profile of rhFSH charge analogues after
ConA chromatography
More acidic/sialylated rhFSH (6.8 mg LER-907) and less
sialylated rhFSH (5.4 mg LER-907) charge analogues were
individually applied to ConA columns. Figure 1 shows the
general outline of the analytical procedure. The elution
protocol was identical to the one described in the previous
paragraph.Hormone measurements
The rhFSH content of samples was measured using an in-house
double-antibody RIA with reagents provided by NIDDK
(Bethesda, MD, USA). The RP LER-907 (1 mg LER-907Z
53 IU Second International Reference Preparation, hMG) was
used to construct the standard curve. The polyclonal antibody,
anti-hFSH-6, was used as antiserum. Purified hFSH (hFSH-I-
SIAFP-1) was iodinated using the chloramine-T method
(Greenwood et al. 1963). To minimize the effects of interassay
variations, as well as to determine the degree of parallelism
between the unknown samples and the FSH standards, all
glycoform preparations were analysed at multiple dose levels
in the same assay run. The intra- and interassay coefficients of
variation were !9 and 12% respectively. Simultaneous curve
fitting of the dose–response curves obtained in the RIA of the
glycoforms revealed no significant differences among the
slopes generated by the standard LER-907 and the different
rhFSH glycosylation variants, suggesting that the glycoforms
were equally recognized by the antibody. rhFSH is expressed in
terms of hFSH-2 standard (NIDDKNHPP).
Inhibin A and B levels in the culture media were measured
using specific two-site ELISAs (Oxford Bio-Innovation Ltd.,
Oxon, UK) as described previously (Groome et al. 1994, 1996).
Recombinant human inhibin A and B (Genentech, San
Francisco, CA, USA) were used as standards. The assay
sensitivity was 7 pg/ml for inhibin A and 15 pg/ml for inhibin
B. Inhibin A had !0.5% cross-reaction in the inhibin B assay
whereas inhibin B had !0.1% cross-reaction in the inhibin A
assay. The human inhibin A and B assays had been validated
and successfully used in the rat (Lanuza et al. 1999, Arai
et al. 2002).Statistical analysis
Results are expressed as meanGS.E.M. Data were log trans-
formed before statistical analysis when appropriate; percentage
of FSH glycosylation variants was transformed to arcsine (p)1/2,
where 0!P!1. Statistical analysis was performed using one-
way ANOVA followed by the Tukey–Kramer test for multiple
comparisons. The significance was established when the two-
tailed P value was !0.05. All statistical analyses were
performed using GraphPad Prism version 5.00 for Windows
(GraphPad Software, San Diego, CA, USA).Reproduction (2013) 145 127–135
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